DiamiR Biosciences Corp. (DIMR)
DiamiR Biosciences was planning to go public, but the IPO was withdrawn on Jul 14, 2025.
Stock Price: Pending
IPO price not available yet
DiamiR Biosciences Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 1.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -173.40% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $264,193 |
| Profits Per Employee | -$126,748 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DIMR has paid $88,699 in taxes.
| Income Tax | 88,699 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIMR had revenue of $1.32 million and -$633,740 in losses.
| Revenue | 1.32M |
| Gross Profit | 1.32M |
| Operating Income | -500,441 |
| Pretax Income | -545,041 |
| Net Income | -633,740 |
| EBITDA | -457,514 |
| EBIT | -500,441 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $141,379 in cash and $586,201 in debt, giving a net cash position of -$444,822.
| Cash & Cash Equivalents | 141,379 |
| Total Debt | 586,201 |
| Net Cash | -444,822 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -297,602 |
| Book Value Per Share | n/a |
| Working Capital | 62,407 |
Cash Flow
In the last 12 months, operating cash flow was -$240,937 and capital expenditures -$1,278, giving a free cash flow of -$242,215.
| Operating Cash Flow | -240,937 |
| Capital Expenditures | -1,278 |
| Free Cash Flow | -242,215 |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -37.88% and -47.98%.
| Gross Margin | 100.00% |
| Operating Margin | -37.88% |
| Pretax Margin | -41.26% |
| Profit Margin | -47.98% |
| EBITDA Margin | -34.63% |
| EBIT Margin | -37.88% |
| FCF Margin | -18.34% |
Dividends & Yields
DIMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |